Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions

British Journal of Dermatology

Volumn 160, Issue 4, 2009, Pages 786-794

  Waton, J ^a   Trechot P ^a   Loss Ayav, C ^a   Schmutz, J L ^a   Barbaud, A ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Cutaneous adverse drug reaction; Drug allergy; drug causality assessment; Drug skin test; negative predictive value; Rechallenge

Indexed keywords

ALDACTAZINE; ALLOPURINOL; AMOXICILLIN; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; BUDESONIDE; CARBOCISTEINE; CARBOXYMETHYLCELLULOSE; CEFATRIZINE; CEFPODOXIME; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; DICLOFENAC; DILTIAZEM; DOXYCYCLINE; IBUPROFEN; IODIXANOL; LIDOCAINE; MEBEVERINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENORO; SPIRAMYCIN; TRAMADOL; UNINDEXED DRUG; VANCOMYCIN; ZINC;

ANGIONEUROTIC EDEMA; ARTICLE; BURN; CHRONOLOGY; CLINICAL FEATURE; CONTACT DERMATITIS; CROSS REACTION; CUTANEOUS ADVERSE DRUG REACTION; DIAGNOSTIC TEST; DRUG CLASSIFICATION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECZEMA; FIXED DRUG ERUPTION; HUMAN; INTRACUTANEOUS TEST; MACULOPAPULAR RASH; PATCH TEST; PREDICTION AND FORECASTING; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; RETROSPECTIVE STUDY; SKIN TEST; SUBSTITUTION TEST; URTICARIA;

ADULT; BRONCHIAL PROVOCATION TESTS; CROSS REACTIONS; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SKIN TESTS;

EID: 62649121885     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08975.x     Document Type: Article

References (31)

1. Barbaud A, Reichert-Penetrat S, Trechot P et al. The use of skin testing in the investigation of cutaneous adverse reaction. Br J Dermatol 1998 139 : 49 58.
2. Lammintausta K, Kortekangas-Savolainen O. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol (Stockh) 2005 85 : 491 6.
3. Barbaud A, Goncalo M, Bruynzeel D et al. European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001 45 : 321 8.
4. Sanchez-Borges M, Capriles-Hulett A, Caballero F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol 2002 3 : 599 607.
5. Moore N, Biour M, Paux G et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985 ii : 1056 8.
6. Jean-Pastor MJ. Critères d'imputabilité des atteintes cutanées médicamenteuses: atteintes cutanées. Therapie 2002 57 : 265 8.
7. Wöhrl S, Geusau A. Patients with drug reactions - is it worth testing? Allergy 2006 61 : 928 34.
8. Ponvert C, Le Clainche L, de Blic J et al. Allergy to beta-lactam antibiotics in children. Pediatrics 1999 104 : e45.
9. Romano A, Quaratino D, Papa G et al. Aminopenicillin allergy. Arch Dis Child 1997 76 : 513 17.
10. Torres MJ, Mayorga C, Leyva L et al. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp Allergy 2002 32 : 270 6.
11. Messaad D, Sahla H, Benahmed S et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004 140 : 1001 6.
12. Audicana M, Bernaola G, Urrutia I et al. Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin. Allergy 1994 49 : 108 13.
13. Novalbos A, Sastre J, Cuesta J et al. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy 2001 31 : 438 43.
14. Romano A, Gueant-Rodriguez RM, Viola M et al. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004 141 : 16 22.
15. Demoly P, Benahmed S, Valembois M et al. L'allergie aux macrolides: revue de la littérature. Presse Med 2000 29 : 321 6.
16. Kvedariene V, Bencherioua AM, Messaad D et al. The accuracy of the diagnosis of suspected paracetamol (acetaminophen) hypersensitivity: results of a single-blinded trial. Clin Exp Allergy 2002 32 : 1366 9.
17. Padial A, Posadas S, Alvarez J et al. Non immediate reactions to systemic corticosteroids suggest an immunological mechanism. Allergy 2005 60 : 665 70.
18. Venturini M, Lobera T, del Pozo MD et al. Immediate hypersensitivity to corticosteroids. J Invest Allergol Clin Immunol 2006 16 : 51 6.
19. Figarella I, Barbaud A, Lecompte T et al. Réaction cutanée d'hypersensibilité retardée avec polysensibilisation aux héparines et héparinoïdes. Ann Dermatol Venereol 2001 128 : 25 30.
20. Jappe U, Juschka U, Kuner N et al. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases. Contact Dermatitis 2004 51 : 67 72.
21. Burgdorff T, Venemalm L, Vogt T et al. IgE-mediated anaphylactic reaction induced by succinate ester of methylprednisolone. Ann Allergy Asthma Immunol 2002 89 : 425 8.
22. Freymond N, Catelain A, Queille E et al. Réaction allergique à la méthylprednisolone. Rev Med Interne 2003 24 : 698 700.
23. Just N, Nyunga M, Lelong J et al. Allergie immédiate aux glucocorticoïdes de synthèse oraux. Rev Med Interne 2005 26 : 331 4.
24. Koch P. Absence de réaction à un héparinoïde recombinant chez un malade polysensibilisé aux héparines standard, de bas poids moléculaire et aux héparinoïdes classiques. Ann Dermatol Venereol 1998 125 : S211 12.
25. Barbaud A. Drug skin tests and systemic cutaneous adverse drug reactions: an update. Expert Rev Dermatol 2007 2 : 481 95.
26. Benahmed S, Picot MC, Hillaire-Buys D et al. Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions. Eur J Clin Pharmacol 2005 61 : 537 41.
27. Dellestable P, Weber-Muller F, Tréchot P et al. Deux médicaments de même imputabilité dans une toxidermie: la positivitéà un des deux n'autorise pas la reprise du second. Ann Dermatol Venereol 2007 134 : 655 8.
28. Matura M, Goossens A. Contact allergy to corticosteroids. Allergy 2000 55 : 698 704.
29. Boehncke WH, Weber L, Gall H. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids. Contact Dermatitis 1996 35 : 73 5.
30. Poza-Guedes P, Gonzalez-Perez R, Canto G. Different patterns of cross-reactivity in non-immediate hypersensitivity to heparins: from localized to systemic reactions. Contact Dermatitis 2002 47 : 244 5.
31. Koch P. Delayed-hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and the new synthetic anticoagulant fondaparinux. Contact Dermatitis 2004 49 : 276 80.